发明名称 PROCEDE D'OBTENIR 1,2,5-O0ADIAZOLE-2-O0YDES
摘要 Pharmacologically-valuable 3,4-(bis-substituted)-1,2,5-oxdiazole 2-oxides of formula I <IMAGE> (I) [wherein R denotes -NHR1, -NR2R3, -NHR4OR2, -NHR5COR6 or <IMAGE> R1 denotes alkyl having from 1 to 6 C atoms or cycloalkyl having 4 to 7 ring C atoms, R2 and R3 denote alkyl having from 1 to 4 C atoms, R4 denotes an alkylene radical of the formula -CnH2n-(wherein n denotes 2, 3 or 4), R5 denotes an alkylene radical of the formula -CmH2m- (wherein m denotes 1, 2 or 3), R6 denotes -OR2, -NHR1, -NR2R3 or -NH2, X denotes -(CH2)p-, -(CH2)2-O-(CH2)2- or <IMAGE> and p is 4, 5 of 6] and their pharmacologically-acceptable acid-addition compounds are prepared by elimination of hydrogen chloride from a hydroxamoyl chloride of the formula R-CO-C(Cl)=NOH (II) and dimerization. If desired, the resulting reaction product is subsequently converted into an acid-addition compound. The compounds and pharmaceutical preparations thereof are useful for treating and for prophylaxis of cardiovascular diseases.
申请公布号 RO84099(A) 申请公布日期 1984.05.12
申请号 RO19810106033 申请日期 1981.12.17
申请人 CASSELLA AG,DE 发明人 SCHONAFINGER,KARL,DE;BOYERLE,RUDI,DE;MOGILEV,ANTON,DE;BOHN,HELMUT,DE;JUST,MELITTA,DE;MARTORANA,PIERO,DE;NITZ,ROLF E.,DE
分类号 A61K31/41;A61K31/42;A61K31/4245;A61K31/445;A61K31/475;A61K31/495;A61K31/496;A61K31/50;A61K31/505;A61K31/535;A61K31/5377;A61K31/54;A61K31/55;A61P9/00;A61P9/08;A61P9/10;A61P9/12;C07D271/08 主分类号 A61K31/41
代理机构 代理人
主权项
地址